VERIFICATION OF A TUMOR LESION OF INTRAPELVIC LYMPH NODES AFTER RADICAL PROSTATECTOMY. THE FIRST EXPERIENCE
https://doi.org/10.17650/1726-9776-2012-8-3-88-91
Abstract
Objective: to study the possibilities of transrectal ultrasound scan (TRUS) and magnetic resonance imaging (MRI) in identifying and verifying a tumor lesion of intrapelvic lymph nodes (LN) in patients with biochemical recurrence after radical prostatectomy.
Subjects and methods. Metastatic tumor lesion of intrapelvic LNs was verified in 4 patients by transrectal ultrasound (US)-guided needle biopsies. All the patients underwent multi-parametric MRI studies and TRUS.
Results. The application of current MRI technologies (for qualitative and quantitative analysis of diffusion-weighted images and for postcontrast sequences) could detect and judge with confidence the metastatic lesion of intrapelvic LNs. TRUS permits clearly visualizing pathologically altered LNs, by taking into account their MRI pattern and verifying their tumor lesion by US-guided core needle biopsy.
Conclusion. The combined use of multi-parametric MRI and TRUS provides a means for diagnosing and verifying the tumor lesion of pelvic LNs in patients after prostatectomy.
About the Authors
V. V. Kapustin
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
V. I. Shirokorad
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
A. I. Gromov
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
D. S. Koshurnikov
Moscow City Cancer Hospital Sixty-Two
Russian Federation
Russian Federation
References
1. Клинические рекомендации. Онкология. Под ред. В.И. Чиссова, С.Л. Дарьяловой. М.: ГЭОТАР-Медиа, 2008. С. 428−30.
2. Scattoni V., Montorsi F., Piccho M. et al. Diagnosis of local recurrence after radical prostatectomy. BJU Int 2004:93:680−8.
3. Roscigno M., Scattoni V., Raber M. et al. Role of prostate fossa ultrasonography in the diagnosis of local recurrence after radical prostatectomy in case of PSA failure. Arch Ital Urol Androl 2002;74(4):304−8.
4. Vargas H.A., Wassberg C., Akin O., Hricak H. MR imaging of treated prostate cancer. Radiology 2012;262(1):26−42.
5. Giannarini G., Nguyen D.P., Thalmann G.N., Thoeny H.C. Diffusionweighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience. Eur Urol 2012;61(3):616−20.
6. Meijer H.J., van Lin E.N., Debats O.A. et al. High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 2001;82:1405−10.
7. Valotto C., Falconieri G., Pizzolitto S. et al. Residual prostatic tumour in the surgical bed following radical prostatectomy in organconfined prostate cancer: possible prognostic significance. Arch Ital Urol Androl 2011; 83(2):78−82.
8. Rigatti P., Suardi N., Briganti A. et al. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C] choline positron emission tomography/computed tomography. Eur Urol 2011;60(5): 935−43.
Review
For citations:
Kapustin V.V., Shirokorad V.I., Gromov A.I., Koshurnikov D.S. VERIFICATION OF A TUMOR LESION OF INTRAPELVIC LYMPH NODES AFTER RADICAL PROSTATECTOMY. THE FIRST EXPERIENCE. Cancer Urology. 2012;8(3):88-91. (In Russ.) https://doi.org/10.17650/1726-9776-2012-8-3-88-91
Views:
962
Email this article 